In Situ Vaccination with a Vpr-Derived Peptide Elicits Systemic Antitumor Immunity by Improving Tumor Immunogenicity

<b>Background:</b> Cancer vaccines represent a groundbreaking advancement in cancer immunotherapy, utilizing tumor antigens to induce tumor-specific immune responses. However, challenges like tumor-induced immune resistance and technical barriers limit the widespread application of prede...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Danjie Pan, Ling Du, Jiayang Liu, Kudelaidi Kuerban, Xuan Huang, Yue Wang, Qiuyu Guo, Huaning Chen, Songna Wang, Li Wang, Pinghong Zhou, Zhefeng Meng, Li Ye
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Subjects:	viral protein R cell apoptosis immunogenic cell death tumor immunotherapy tumor vaccine
Online Access:	https://www.mdpi.com/2076-393X/13/7/710